Singular Genomics Systems Inc (OMIC)
22.31
+8.85
(+65.75%)
USD |
NASDAQ |
Nov 04, 16:00
22.03
-0.28
(-1.26%)
After-Hours: 07:46
Singular Genomics Systems Total Assets (Quarterly): 220.00M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 220.00M |
| March 31, 2024 | 239.10M |
| December 31, 2023 | 265.47M |
| September 30, 2023 | 284.52M |
| June 30, 2023 | 283.98M |
| March 31, 2023 | 305.47M |
| December 31, 2022 | 327.98M |
| September 30, 2022 | 345.48M |
| Date | Value |
|---|---|
| June 30, 2022 | 366.41M |
| March 31, 2022 | 342.11M |
| December 31, 2021 | 355.65M |
| September 30, 2021 | 370.83M |
| June 30, 2021 | 383.98M |
| March 31, 2021 | 155.62M |
| December 31, 2020 | 30.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
30.50M
Minimum
Dec 2020
383.98M
Maximum
Jun 2021
285.14M
Average
305.47M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Bruker Corp | 5.903B |
| Azenta Inc | 2.323B |
| Harvard Bioscience Inc | 128.91M |
| Bionano Genomics Inc | 129.36M |
| Akoya Biosciences Inc | 143.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 82.30M |
| Shareholders Equity (Quarterly) | 137.71M |
| Debt to Equity Ratio | 0.0461 |
| Current Ratio | 8.774 |
| Net Debt Paydown Yield | 3.56% |